Clarity Pharmaceuticals Ltd (ASX:CU6)
Australia flag Australia · Delayed Price · Currency is AUD
2.690
+0.010 (0.37%)
Aug 7, 2026, 4:10 PM AEST

Clarity Pharmaceuticals Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Revenue
10.589.4611.519.86.463.2
Revenue Growth
11.80%-17.76%17.41%51.74%102.07%14.62%
Gross Profit
10.589.4611.519.86.463.2
Operating Income
-95.96-69.09-44.21-26.36-17.05-10.31
Net Income
-96.35-64.3-42.32-24.6-23.75-10.22
Earnings Per Share
-0.28-0.20-0.15-0.10-0.10-0.06
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Net Cash (Debt)
226.2584.12136.5165.0192.3418.94
Net Cash Growth
168.97%-38.38%109.96%-29.59%387.54%202.28%
Net Cash Per Share
0.660.260.500.250.370.11
Cash & Investments
226.2584.12136.5165.0192.3418.94

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Cash Flow
-72.26-54.77-43.24-27.5-13.31-7.68
Capital Expenditures
-0.34-0.18-0.5-0.05-0.21-0.06
Free Cash Flow
-72.59-54.95-43.74-27.55-13.53-7.74
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-906.99%-730.16%-384.24%-269.00%-263.94%-322.65%
Pretax Margin
-902.89%-675.05%-365.26%-249.98%-367.51%-319.77%
Profit Margin
-910.66%-679.45%-367.82%-251.03%-367.78%-319.77%
FCF Margin
-686.15%-580.71%-380.14%-281.07%-209.43%-242.06%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PS Ratio
94.8684.93146.7918.6220.37-